Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma.

Saved in:
Bibliographic Details
Title: Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma.
Authors: Gabor KM; Department of Pediatrics and Pediatric Health Care Center, Faculty of Medicine, University of Szeged, Szeged, Hungary., Sapi Z; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University Budapest, Budapest, Hungary., Tiszlavicz LG; Department of Pediatrics and Pediatric Health Care Center, Faculty of Medicine, University of Szeged, Szeged, Hungary., Fige A; Department of Pediatrics and Pediatric Health Care Center, Faculty of Medicine, University of Szeged, Szeged, Hungary., Bereczki C; Department of Pediatrics and Pediatric Health Care Center, Faculty of Medicine, University of Szeged, Szeged, Hungary., Bartyik K; Department of Pediatrics and Pediatric Health Care Center, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2018 Feb; Vol. 65 (2). Date of Electronic Publication: 2017 Aug 26.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first